ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-OR021

Tubular Morphometric Signatures (TMS)-Based FSGS/Minimal Change Disease (MCD) Patient Retrieval

Session Information

Category: Artificial Intelligence, Digital Health, and Data Science

  • 300 Artificial Intelligence, Digital Health, and Data Science

Authors

  • Fan, Fan, Department of Biomedical Engineering, Emory University and Georgia Institute of Technology, Atlanta, Georgia, United States
  • Nair, Viji, University of Michigan Department of Internal Medicine, Ann Arbor, Michigan, United States
  • Smith, Cathy, University of Michigan Department of Internal Medicine, Ann Arbor, Michigan, United States
  • Eichinger, Felix H., University of Michigan Department of Internal Medicine, Ann Arbor, Michigan, United States
  • McCown, Phillip J., University of Michigan Department of Internal Medicine, Ann Arbor, Michigan, United States
  • Demeke, Dawit S., University of Michigan Department of Pathology, Ann Arbor, Michigan, United States
  • Wang, Bangchen, Department of Pathology, Division of AI & Computational Pathology, Duke University, Durham, North Carolina, United States
  • Ozeki, Takaya, Nagoya University Graduate School of Medicine, Department of Nephrology, Nagoya, Japan
  • Jacobs, Jackson, Department of Biomedical Engineering, Emory University and Georgia Institute of Technology, Atlanta, Georgia, United States
  • Liu, Qian, Children’s Hospital of Philadelphia Research Institute, Philadelphia, Pennsylvania, United States
  • Bitzer, Markus, University of Michigan Department of Internal Medicine, Ann Arbor, Michigan, United States
  • Mariani, Laura H., University of Michigan Department of Internal Medicine, Ann Arbor, Michigan, United States
  • Lafata, Kyle Jon, Duke University Department of Radiation Oncology, Durham, North Carolina, United States
  • Holzman, Lawrence B., Department of Medicine, Division of Nephrology and Hypertension, University of Pennsylvania, Philadelphia, Pennsylvania, United States
  • Kretzler, Matthias, University of Michigan Department of Internal Medicine, Ann Arbor, Michigan, United States
  • Madabhushi, Anant, Department of Biomedical Engineering, Emory University and Georgia Institute of Technology, Atlanta, Georgia, United States
  • Zee, Jarcy, Children’s Hospital of Philadelphia Research Institute, Philadelphia, Pennsylvania, United States
  • Hodgin, Jeffrey B., University of Michigan Department of Pathology, Ann Arbor, Michigan, United States
  • Barisoni, Laura, Department of Pathology, Division of AI & Computational Pathology, Duke University, Durham, North Carolina, United States
  • Janowczyk, Andrew, Department of Biomedical Engineering, Emory University and Georgia Institute of Technology, Atlanta, United States
Background

The clinical, morphologic, and treatment heterogeneity among patients with FSGS/MCD poses a major barrier to understanding disease trajectories. Here, we evaluated whether tubular pathomic–derived features could support precision medicine by enabling nephrologists to identify patients with similar morphologic characteristics and explore their disease trajectories.

Methods

We applied image processing and deep learning algorithms to periodic acid–Schiff–stained whole-slide images from 246 NEPTUNE/CureGN FSGS/MCD patients with visual descriptor scoring and longitudinal clinical data. Tubular substructures—epithelium, nuclei, basement membrane, and lumen—were segmented, from which 99 pathomic features were extracted. Using these features, we computationally derived 14 TMS via non-negative matrix factorization. Tubule-level TMS was summarized at the patient level using mean.
Nearest-neighbor retrieval was performed using k-nearest neighbors (KNN) with Euclidean distance to identify patients with similar TMS profiles. For the MCD cohort (Fig. 1), each adult participant (query case) was compared to five adult participants with the most similar TMS-derived biopsy profiles. Comparisons were made across (a) biopsy visual descriptor scores [% global/segmental sclerosis, interstitial fibrosis and tubular atrophy (IFTA), inflammation, and arteriosclerosis], (b) clinical characteristics, and (c) treatment exposure.

Results

While expected similarities were observed between the query participant and nearest neighbors in tubular visual scoring, substantial variability remained in other tubulointerstitial, vascular, and glomerular features across cases. Divergent clinical trajectories were observed, often accompanied by differences in treatment exposure.

Conclusion

The pathomic signature–based patient retrieval framework enables structured comparison of therapeutic strategies and associated responses within phenotypically matched groups, supporting case-based interpretation, hypothesis generation, and exploratory evaluation of treatment decisions.

Acknowledgment

ChatGPT (OpenAI) was used for language editing and writing assistance. Authors reviewed and take full responsibility for the final content.

Funding

  • NIDDK Support